Kaufman HL - Search Results

1

Initial clinical response predicts outcome and is associated with dose schedule in metastatic melanoma and renal cell carcinoma patients treated with high-dose interleukin 2.

Spanknebel K, Cheung KY, Stoutenburg J, Hurst-Wicker K, Hesdorffer C, Deraffele G, Kaufman HL. Spanknebel K, et al. Among authors: kaufman hl. Ann Surg Oncol. 2005 May;12(5):381-90. doi: 10.1245/ASO.2005.03.063. Epub 2005 Apr 4. Ann Surg Oncol. 2005. PMID: 15915372

2

Surgical treatment of stage IV melanoma.

Spanknebel K, Kaufman HL. Spanknebel K, et al. Among authors: kaufman hl. Clin Dermatol. 2004 May-Jun;22(3):240-50. doi: 10.1016/j.clindermatol.2003.12.004. Clin Dermatol. 2004. PMID: 15262311 Review.

3

Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma.

Cesana GC, DeRaffele G, Cohen S, Moroziewicz D, Mitcham J, Stoutenburg J, Cheung K, Hesdorffer C, Kim-Schulze S, Kaufman HL. Cesana GC, et al. Among authors: kaufman hl. J Clin Oncol. 2006 Mar 1;24(7):1169-77. doi: 10.1200/JCO.2005.03.6830. J Clin Oncol. 2006. PMID: 16505437

4

Treatment of pediatric ocular melanoma with high-dose interleukin-2 and thalidomide.

Soni S, Lee DS, DiVito J Jr, Bui AH, DeRaffele G, Radel E, Kaufman HL. Soni S, et al. Among authors: kaufman hl. J Pediatr Hematol Oncol. 2002 Aug-Sep;24(6):488-91. doi: 10.1097/00043426-200208000-00016. J Pediatr Hematol Oncol. 2002. PMID: 12218599 Review.

5

Management of metastatic malignant melanoma of the bladder.

Lee CS, Komenaka IK, Hurst-Wicker KS, Deraffele G, Mitcham J, Kaufman HL. Lee CS, et al. Among authors: kaufman hl. Urology. 2003 Aug;62(2):351. doi: 10.1016/s0090-4295(03)00354-6. Urology. 2003. PMID: 12893353

6

Adjuvant therapy for malignant melanoma.

Stoutenburg JP, Schrope B, Kaufman HL. Stoutenburg JP, et al. Among authors: kaufman hl. Expert Rev Anticancer Ther. 2004 Oct;4(5):823-35. doi: 10.1586/14737140.4.5.823. Expert Rev Anticancer Ther. 2004. PMID: 15485316 Review.

7

Management of metastatic melanoma to the breast with high-dose interleukin-2 and surgical resection.

Komenaka IK, DeRaffele G, Hurst-Wicker KS, Kaufman HL. Komenaka IK, et al. Among authors: kaufman hl. Breast J. 2005 Mar-Apr;11(2):158-9. doi: 10.1111/j.1075-122X.2005.21627.x. Breast J. 2005. PMID: 15730472 No abstract available.

8

Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma.

Kaufman HL, Deraffele G, Mitcham J, Moroziewicz D, Cohen SM, Hurst-Wicker KS, Cheung K, Lee DS, Divito J, Voulo M, Donovan J, Dolan K, Manson K, Panicali D, Wang E, Hörig H, Marincola FM. Kaufman HL, et al. J Clin Invest. 2005 Jul;115(7):1903-12. doi: 10.1172/JCI24624. Epub 2005 Jun 2. J Clin Invest. 2005. PMID: 15937544 Free PMC article. Clinical Trial.

9

Local delivery of vaccinia virus expressing multiple costimulatory molecules for the treatment of established tumors.

Kaufman HL, Cohen S, Cheung K, DeRaffele G, Mitcham J, Moroziewicz D, Schlom J, Hesdorffer C. Kaufman HL, et al. Hum Gene Ther. 2006 Feb;17(2):239-44. doi: 10.1089/hum.2006.17.239. Hum Gene Ther. 2006. PMID: 16454657 Clinical Trial.

10

Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma.

Kaufman HL, Taback B, Sherman W, Kim DW, Shingler WH, Moroziewicz D, DeRaffele G, Mitcham J, Carroll MW, Harrop R, Naylor S, Kim-Schulze S. Kaufman HL, et al. J Transl Med. 2009 Jan 7;7:2. doi: 10.1186/1479-5876-7-2. J Transl Med. 2009. PMID: 19128501 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters